drugset / Trial / NCT02722083

Exploratory Study for Allergy Relief Onset

NCT02722083

Phase 2 Terminated 1 enrolled Bayer
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of the study is to explore the onset of effect of an antihistamine in a controlled environment.

Timeline

Start
2016-05-07
Primary completion
2016-05-27
Completion
2016-07-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorpheniramine Unknown 4 mg Oral

Indications